Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder
Launched by IRCCS EUGENIO MEDEA · Mar 27, 2025
Trial Information
Current as of May 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children with Attention Deficit Hyperactivity Disorder (ADHD) focus their attention over time. Researchers are using a new test called the "Sustained-Paced Finger Tapping" to see if kids with ADHD have difficulties sustaining their internal attention compared to children without ADHD. The goal is to better understand how attention works in these children and to validate the effectiveness of this new test.
The study is looking for participants aged between 2 and 18 years who have been diagnosed with ADHD, including those who have not yet started any medication. Children with a normal IQ (intelligence quotient) are also eligible if they do not show symptoms of ADHD. However, children with other conditions, such as autism, severe mood disorders, or certain neurological issues, cannot participate. If selected, participants will take part in the finger tapping test, which will help researchers learn more about attention in children with ADHD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ADHD Group (1) Subjects with a diagnosis of ADHD of any severity level and subtype
- • ADHD Group (2) "Medication-naive" ADHD subjects, meaning subjects who have not been prescribed and/or have not yet started any pharmacological treatment for ADHD
- • ADHD Group (3) IQ ≥ 70
- • Non-ADHD Group, Normal IQ
- Exclusion Criteria:
- • for both groups, symptomatology suggestive of autism spectrum disorders, psychotic disorders, mood disorders, and anxiety disorders
- • for both groups, use of psychotropic drugs
- • for both groups, subjects with cerebral palsy and/or neuromotor and neuromuscular disorders
- • for both groups, CNS diseases, e.g., epilepsy and/or neurodegenerative diseases, or central nervous system injuries resulting from, for example, head trauma or stroke
- • for the non-ADHD group, presence of ADHD symptoms
About Irccs Eugenio Medea
IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brindisi, , Italy
Lecce, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported